August 16, 2016 / 4:46 PM / 2 years ago

BUZZ-U.S. STOCKS ON THE MOVE-Concho, Sito Mobile, Coty, ParkerVision

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter,; for the Morning News Call newsletter,

The Dow Jones Industrial Average was down 0.28 percent at 18,584.79, the S&P 500 was down 0.34 percent at 2,182.7 and the Nasdaq Composite was down 0.44 percent at 5,238.669.

** BHP BILLITON LTD, $31.66, +1.47 pct

The diversified miner reported a record $6.4 billion annual loss on Tuesday, hammered by a bad bet on shale, a dam disaster in Brazil and a commodities slump, but sounded a note of optimism as prices stabilize and its costs fall.

** ADVANCE AUTO PARTS INC, $162.57, -3.09 pct

The U.S. auto parts retailer reported a 4.8 percent fall in quarterly revenue as it grapples with “service shortfalls” and the unavailability of parts.


The company said it was exploring strategic alternatives after its experimental drug failed a late-stage study in patients with advanced prostate cancer.

** PRAXAIR INC, $123.87, +4.95 pct

The U.S. industrial gas supplier and German peer Linde AG have held initial talks about a merger to create a market leader with a value of more than $60 billion, people familiar with the matter said.

** HAIN CELESTIAL GROUP INC, $39.8554, -25.36 pct

The organic food maker said late on Monday it had started an internal probe into its accounting practices and would not meet its full-year forecasts, prompting several brokerages to cut ratings and price targets on its stock. Hain, which makes Arrowhead Mills baking products and Deboles pasta, said it would delay filing its fourth-quarter report pending the investigation into its internal financial controls and the timing of various concessions granted to certain distributors.

** CONCHO RESOURCES INC, $131.97, -3.28 pct

The oil and gas producer said on Monday it would acquire about 40,000 net acres in the core of Midland Basin in Texas for about $1.63 billion from privately held Reliance Energy. The deal is for about $1.1 billion in cash and 3.96 million of its shares. The company said separately that it would offer 9 million shares in an underwritten public offering.

** ARCH CAPITAL GROUP LTD, $80.58, +4.53 pct

American International Group Inc said on Monday it would sell its mortgage-guaranty unit to Arch Capital Group for about $3.4 billion.


The real estate investment trust commenced a public offering of 11 million common shares at $30.75 per share.

** TJX COS INC, $78.14, -5.59 pct

The operator of off-price retail chains T.J. Maxx and Marshalls, forecast current-quarter profit below analysts’ estimates due to wage increases and a strong dollar, which is eroding revenue from outside the United States.

** UNIVAR INC, $18.77, -6.62 pct

The chemicals distributor said the offering of 20.9 million of its shares by shareholders was priced at $19 per share.

** CINTAS CORP, $114.86, +6.93 pct

** G&K SERVICES INC, $96.695, +17.73 pct

Cintas Corp, which sells and leases uniforms, said it would buy smaller rival G&K Services for about $2.2 billion, including debt, to strengthen its presence in the United States and Canada.

** CST BRANDS INC, $47.43, +7.02 pct

** CROSSAMERICA PARTNERS LP, $25.92, +6.49 pct

Canadian convenience store operator Alimentation Couche-Tard Inc is in the lead to acquire CST Brands, a U.S.-based convenience store retailer, according to two sources familiar with the matter. San Antonio, Texas-based CST owns and operates convenience stores and gas stations in Canada and the United States, and it controls the general partner of gas station company CrossAmerica Partners.

** COTY INC, $28.04, -5.75 pct

The beauty products maker reported its second straight quarterly loss, hurt by a jump in costs to integrate beauty brands acquired from Procter & Gamble and a slowdown in sales of core brands.

** DICK’S SPORTING GOODS INC, $58.84, +7.20 pct

The sports goods retailer reported an unexpected rise in its second-quarter comparable store sales, helped by demand for footwear, accessories and apparel. Comparable sales rose 2.8 percent. Analysts on average had expected a drop of 2.5 percent, according to Consensus Metrix.


The drug developer said an independent data and safety monitoring panel recommended a late-stage study testing its pancreatic enzyme replacement therapy, Sollpura, continue after it found no safety concerns. The company’s other experimental drug, blisibimod, is being tested for use in lupus, an autoimmune disorder.

** SHOPIFY INC, $38.3, -2.00 pct

The Canadian e-commerce software maker said on Monday it would offer 5 million class A subordinate shares and selling shareholders would offer 2.5 million shares.

** SITO MOBILE INC, $5.13, +25.43 pct

Three of four brokerages covering the mobile advertising services provider’s stock raise their price targets as the company’s net revenue more than doubled to $9.9 million in the second quarter, beating the average analyst estimate of $7.5 million.

** PARKERVISION INC, $5.65, -7.83 pct

The semiconductor technology developer’s net loss widened in the second quarter due to mounting litigation fees.

** RUBICON PROJECT INC, $9.25, -4.15 pct

First Analysis Securities Corp cut its rating on the online advertising service provider’s stock to “equal-weight” from “overweight” and price target to $10.50 from $22, citing worries about the company’s cloudy outlook. “We don’t have confidence in even loosely pegging what the company’s overall return to growth looks like,” analyst Craig Nankervis wrote in a note.

** INNERWORKINGS INC, $9.505, +12.35 pct

Brokerage Craig-Hallum raised its price target on the marketing services firm’s stock to $11 from $10, saying InnerWorkings is executing with “almost surgical precision.” InnerWorkings’ second-quarter profit and revenue beat estimates, helped by the expansion of a contract with a large food and beverage company. The company, identified as Mondelez International Inc by Craig-Hallum, has expanded its contract with InnerWorkings to include 16 Latam countries.

** VERTEX PHARMACEUTICALS INC, $100.19, -2.23 pct

The drugmaker halted a late-stage study testing a combination therapy in some patients with cystic fibrosis, a gene defect that disrupts functions of lungs and the digestive system. (Compiled by Akankshita Mukhopadhyay in Bengaluru; Editing by Kirti Pandey)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below